Preliminary Studies of the Toxicity of Agaricus Bisporous Aqueous Enzymatic Extracts (AbAEE) In Rats
|Author/s||Carbonero Aguilar, María del Pilar
Falcón García, Gonzalo
Gallego Yerga, Paloma
Campo, J.A. del
Moreno Navarro, Isabel María
Bautista Palomas, Juan Dionisio
|Department||Universidad de Sevilla. Departamento de Bioquímica y Biología Molecular
Universidad de Sevilla. Departamento de Nutrición y Bromatología, Toxicología y Medicina Legal
|Abstract||The health benefits of extracts from Agaricus bisporus greatly extend its use as components of new functional foods for the treatment and prevention of diseases, rather than restricting it to a good food with high nutritional ...
The health benefits of extracts from Agaricus bisporus greatly extend its use as components of new functional foods for the treatment and prevention of diseases, rather than restricting it to a good food with high nutritional value and good flavor. A. bisporus aqueous enzymatic extracts (AbAEE) have unique flavor, good taste, and health benefits which makes it a good candidate for its incorporation in different matrices for development of new functional foods and nutraceuticals. The potential use of AbAEE as nutraceutical or incorporated as a part of new functional foods requires its characterization and a subsequent food safety study. The focus of this paper was to carry out a preliminary toxicological study on experimental animals (rats in this case) by acute and sub-chronic oral administration. To evaluate potential adverse effects of AbAEE at high doses the acute toxic class method was used. After administration of the preset doses, behavior changes, toxic symptoms, and deaths were observed continuously for 1 h after treatment and then intermittently at 4th, 8th and 24th h. After these initial observations, the rats were further observed for up to 14 consecutive days for any signs of toxicity and/or death. Because of the likelihood that the results obtained in this preliminary acute toxicity test have a direct relevance for protecting human health with respect to the use of AbAEE as a functional food or nutraceutial, an additional upper dose level of 5000 mg/kg b.wt. was used. Since no death was observed, the LD50 could not be estimated but is expected to exceed 5000 mg/kg and this extract could be classified as hazard category 5 (in Globally Harmonized Classification System for Chemical Substances and Mixtures.) or even unclassified for its acute toxicity by the oral route. The sub-chronic oral toxicity study of AbAEE (250 and 500 mg/kg b.wt. day) did not induce significant alterations in almost all hematological and biochemical parameters in rats. Therefore, the overall results of the present study provide supportive data on the use of AbAEE and provide a promising first step for their use as component of new functional foods or as nutraceutical. Though, further studies in both, animals and humans are needed for better evaluation of the food safety of this extract.
|Funding agencies||Ministerio de Economía y Competitividad (MINECO). España
European Commission (EC). Fondo Europeo de Desarrollo Regional (FEDER)
|Citation||Carbonero Aguilar, M.d.P., Falcón García, G., Gallego Yerga, P., Campo, J.A.d., Moreno Navarro, I.M. y Bautista Palomas, J.D. (2018). Preliminary Studies of the Toxicity of Agaricus Bisporous Aqueous Enzymatic Extracts (AbAEE) In Rats. Journal of Toxins, 5 (1), 1-7.|